Marina Caldarelli
University of Cambridge
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marina Caldarelli.
Farmaco | 2002
Steven V. Ley; Ian R. Baxendale; Gloria Brusotti; Marina Caldarelli; Alessandro Massi; M. Nesi
Since the early days of combinatorial chemistry solid-phase organic synthesis has been the method of choice for the production of large libraries. Solution-phase synthesis is again gaining importance especially for the synthesis of parallel arrays of smaller, focussed libraries containing single compounds with high degrees of purity. In the field of solution-phase library generation, the use of solid-supported reagents, catalysts and scavengers is emerging as a leading strategy, combining the advantages of both solid-phase organic synthesis (e.g. allowing the employment of an excess of reagent without the need for additional purification steps) and solution-phase chemistry (e.g. the ease of monitoring the progress of the reactions by applying LC-MS, TLC or standard NMR techniques). An account of some of the most recent advances in this area of research will be presented.
Bioorganic & Medicinal Chemistry Letters | 1999
Marina Caldarelli; Joerg Habermann; Steven V. Ley
Polymer-supported reagents and sequestering agents may be used to generate an array of variously substituted hydroxamic acid derivatives as potential inhibitors of matrix metalloproteinases without any chromatographic purification step.
Bioorganic & Medicinal Chemistry Letters | 2000
Paolo Cozzi; Italo Beria; Marina Caldarelli; Cristina Geroni; Nicola Mongelli; Giulia Pennella
Abstract The design, synthesis, in vitro and in vivo activities of novel α-bromoacrylic derivatives of distamycin A, modified at the amidino moiety by the replacement with basic or non-basic groups are reported. In spite of the relevance of these modifications of distamycin frame, the new derivatives are potent cytotoxics. The presence of the amidino moiety, is, therefore, not an absolute requirement for the activity. In particular due to a favorable myelotoxicity/cytotoxicity ratio, guanidino derivative PNU 166196 was selected for clinical development.
Bioorganic & Medicinal Chemistry Letters | 2011
Marina Caldarelli; Mauro Angiolini; Teresa Disingrini; Daniele Donati; Marco Guanci; Stefano Nuvoloni; Helena Posteri; Francesca Quartieri; Marco Silvagni; Riccardo Colombo
The synthesis and SAR of a series of novel pyrazolo-quinazolines as potent and selective MPS1 inhibitors are reported. We describe the optimization of the initial hit, identified by screening the internal library collection, into an orally available, potent and selective MPS1 inhibitor.
Bioorganic & Medicinal Chemistry Letters | 2000
Paolo Cozzi; Italo Beria; Marina Caldarelli; Laura Capolongo; Cristina Geroni; Nicola Mongelli
The design, synthesis, in vitro and in vivo activities of a series of halogenoacrylic derivatives of distamycin A are described. The structure-activity relationships indicate a key role of the reactivity of alpha-halogenoacrylic moiety. The reactivity and the putative alkylating mechanism of these compounds are different from those of the nitrogen mustards and possibly based on a Michael type reaction. This supports the hypothesis that these compounds represent a class of minor groove binders mechanistically different from tallimustine.
Green Chemistry | 2000
Marina Caldarelli; Ian R. Baxendale; Steven V. Ley
This journal is
Journal of The Chemical Society-perkin Transactions 1 | 1999
Marina Caldarelli; Joerg Habermann; Steven V. Ley
Polymer-supported reagents and other solid sequestering agents may be used to generate an array of 1,2,3,4-tetra-substituted pyrrole derivatives without any chromato-graphic purification step.
Bioorganic & Medicinal Chemistry Letters | 1997
Paolo Cozzi; Italo Beria; Giovanni Biasoli; Marina Caldarelli; Laura Capolongo; Cristina Geroni; Nicola Mongelli
Abstract The design, synthesis, and in vitro and in vivo activities of novel benzoyl and cinnamoyl nitrogen mustard and half-mustard derivatives of distamycin A, in which the amidino moiety has been replaced by moieties of different physico-chemical features, are described and structure-activity relationships are discussed. Some amidino-modified derivatives show significant cytotoxicity and antileukemic activity.
Bioorganic & Medicinal Chemistry Letters | 1997
Paolo Cozzi; Italo Beria; Giovanni Biasoli; Marina Caldarelli; Laura Capolongo; Roberto D'alessio; Cristina Geroni; Stefania Mazzini; Enzio Ragg; Carla Rossi; Nicola Mongelli
Abstract The design, synthesis, in vitro and in vivo activities of novel benzoyl and cinnamoyl nitrogen mustard and half-mustard derivatives of distamycin A are described and structure-activity relationships are discussed. The equipotent activities of N-ethyl-N-chloroethyl half-mustards and N,N-dichloroethyl mustards and the superior activities of cinnamoyl derivatives are the most relevant features of the series.
Bioorganic & Medicinal Chemistry Letters | 2000
Paolo Cozzi; Italo Beria; Marina Caldarelli; Laura Capolongo; Cristina Geroni; Stefania Mazzini; Enzio Ragg
The design, synthesis, and cytotoxic activity of novel benzoyl and cinnamoyl sulfur mustard derivatives of distamycin A are described and structure activity relationships are discussed. These sulfur mustards are more potent cytotoxics than corresponding nitrogen mustards in spite of the lower alkylating power, while their sulfoxide analogues are substantially inactive. Cinnamoyl sulfur mustard derivative (7) proved to be one of the most active distamycin-derived cytotoxics, about 1000 times more potent than melphalan.